Miniaturization(?) after 12 months on oral fin/min compound
    8/2/2026

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Biotin →

    supplement to help with hair texture and quality

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1 mg 1x daily 12 months
    💊 Minoxidil (oral) 3 mg 1x daily 12 months
    💊 Biotin (oral) 1 mg 1x daily 12 months
    the tone is concerned.

    Other terms

    After 12 months on an oral compound of finasteride, minoxidil, and biotin, the user experienced a seasonal shed and noticed thinner hairs at the hairline, raising concerns about ongoing miniaturization. Another user shared a similar experience and mentioned switching to dutasteride after genetic testing showed finasteride was ineffective.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Androgenetic Alopecia: A Review and Emerging Treatments

      research Androgenetic Alopecia: a Review and Emerging Treatments

      1 citations , July 2017 in “Clinical research in dermatology”
      This review covers the pathogenesis, diagnosis, and potential new treatments for androgenetic alopecia but reports no new clinical findings, highlighting an ongoing need for effective therapies.
      Hair Loss in Women: Comprehensive Overview and Treatment Options

      research Hair Loss in Women

      81 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”
      This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.
      Female Pattern Hair Loss: A Clinical, Pathophysiologic, and Therapeutic Review

      research Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review

      66 citations , June 2018 in “International Journal of Women's Dermatology”
      This article discusses treatments for female pattern hair loss, highlighting that oral antiandrogens and topical minoxidil can effectively arrest progression and reverse miniaturization in many patients with mild-to-moderate cases, but it reports no new clinical results.
      Telogen Effluvium: A Review of Acute and Chronic Forms

      research Telogen effluvium

      67 citations , January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      This review discusses telogen effluvium, a common type of hair loss, focusing on differentiation from other conditions and potential causes, but presents no new research findings.
      Diffuse Hair Loss in Women

      research Diffuse hair loss in women

      3 citations , May 2002 in “Therapeutische Umschau”
      This article discusses the challenges in diagnosing and treating diffuse hair loss in women and emphasizes the importance of distinguishing between androgenetic alopecia, chronic telogen effluvium, and psychogenic pseudo effluvium, but reports no new clinical results.
      Efficacy and Safety of a Food Supplement Containing L-Cystine, Serenoa Repens Extract, and Biotin for Hair Loss in Healthy Males and Females: A Prospective, Randomized, Double-Blinded, Controlled Clinical Trial

      research Efficacy and Safety of a Food Supplement Containing L-cystine, Serenoa repens Extract and Biotin for Hair Loss in Healthy Males and Females. A Prospective, Randomized, Double-blinded, Controlled Clinical Trial

      3 citations , January 2017 in “Journal of cosmetology & trichology”
      In this clinical trial, supplementation with Lambdapil® Anti Hair Loss capsules for 6 months significantly improved hair resistance and volume in women and increased the anagen/telogen hair ratio in men, indicating enhanced hair growth compared to the placebo group.